NewsRoom Articles - Page 24 of 153 - PsychedelicNewsWire (PNW)

MondayAug 21, 2023 2:34 pm

After 18 Failed Alcoholism Rehab Attempts, Psychedelics Give Swiss Woman a Reprieve

A Swiss woman who went to rehab 18 times in an attempt to alleviate her alcoholism says she only found relief once she turned to psychedelics. Hallucinogenics have taken over discourse in the psychiatry industry in recent years due to their potential as versatile and effective mental health treatments. Psychedelics present psychiatry with a chance to significantly improve treatment outcomes for a majority of mental health patients. UK-born Amanda has suffered from alcoholism for 20 years and went to rehab nearly 20 times but couldn’t shake the condition. The 50-year-old also suffers from anxiety and severe depression due to childhood…

FridayAug 18, 2023 1:40 pm

Denver to Host Colorado’s First Psychedelic Cup

The Psychedelic Club of Denver has announced that it will hold the city’s first-ever Psychedelic Cup, an event that will see locals compete in cultivating magic mushrooms at home. Club President Jonathan Cherkoss said that the event may also be the first of its kind in the entire state. He noted that the competition would be based on potency analysis rather than psychedelic consumption, stating that Altitude Consulting will conduct the potency testing. Competitors will drop their psychedelic mushroom samples at Altitude Consulting where analysts will conduct a seven-panel test to determine potency levels. Although the competition will have no…

ThursdayAug 17, 2023 2:40 pm

New Study Says Psychedelics Use, Mindfulness Meditation Trigger Leadership Improvements

A new study published in the journal “Frontiers in Psychology” suggests that psychedelic use and mindfulness meditation may trigger leadership improvements and result in positive leadership outcomes. The preliminary study joins a growing body of scientific literature on the impact of psychedelic use on various facets of mental health. Prior research has found that psychedelics may be effective at treating a myriad of severe mental health conditions at minimal doses and with barely any adverse side effects. Researchers have been particularly interested in how psychedelics affect the brain and whether they could leverage these effects to treat anything from anxiety…

WednesdayAug 16, 2023 3:42 pm

BrainFutures, APPA Publish First-Ever Guidelines for Professional Psychedelics Therapists

The American Psychedelic Practitioners Association (APPA) and nonprofit BrainFutures have teamed up to publish the first-ever guidelines for psychedelic-assisted therapists. These new guidelines will establish standards for the relatively new field of psychedelic-assisted therapy as the segment matures amid positive legislative changes and increasing research. A working group of professional experts from different disciplines in the nascent psychedelic field created the guidelines with the aim of educating and guiding therapy practitioners before psychedelic-assisted therapy models start being used outside of research and clinical trials. Psychedelic-assisted therapy presents an exciting new paradigm in psychiatry because it has the potential to deliver…

TuesdayAug 15, 2023 3:16 pm

Planned Clinical Trial to Explore Psychedelics for Gambling Addiction Treatment

Researchers from the Imperial College London’s Center for Psychedelic Research have announced plans to carry out a clinical trial exploring the potential of psychedelics as gambling addiction treatments. After recently studying psychedelics-assisted therapies in treating depression, the center is now looking to investigate whether psilocybin has therapeutic potential against addictions such as gambling. It will be the first study exploring psychedelics as treatments for addiction and is slated to begin in October 2023 with five participants and a control group. According to the study’s recruitment page, the study’s main aim is to determine how gambling-related activities affect the brain’s reward…

MondayAug 14, 2023 3:00 pm

Preliminary Trial Shows Psilocybin Reduces Intensity, Magnitude of Migraines

A preliminary study has revealed that psilocybin, the main psychoactive agent in magic mushrooms, may have applications in migraine treatments. Researchers from Yale School of Medicine recently ran the first-ever clinical trial on the therapeutic potential of psychedelics against migraines. Led by Dr. Emmanuelle Schindler, the research team determined that psilocybin could reduce the number of weekly migraine days by one-half in people with chronic migraines. Furthermore, the researchers determined that even a single dose of the psychedelic could reduce the intensity of migraine attacks by a significant degree in only two weeks with no adverse side effects. Although prior…

FridayAug 11, 2023 3:27 pm

Study Says Psychedelics Trigger Rats’ Brain Waves to Form in Sync

Lund University researchers have come up with a technique that allows them to simultaneously measure electrical signals from 128 different areas of a rat’s brain. Using this groundbreaking technique, the researchers studied different regions of rats’ brains after they took psychedelics to analyze how hallucinogenic drugs affected their neurons. Interestingly, the team found that psychedelics caused brain waves in different regions of the brain to form simultaneously and in sync in rats that were awake. This study was working off the findings of prior research on the impact of electrical oscillations within the brain on rats with Parkinson’s disease. Led…

ThursdayAug 10, 2023 2:13 pm

Senate Committee Says Schedule 1 Classification Hindering Psychedelic Research

A recent spending bill report from a major Senate committee has acknowledged that federal prohibition is hindering comprehensive research into psychedelics. Sections within the report encourage federally sponsored studies involving psychedelics and marijuana but note that the two drugs’ federal status as Schedule I drugs presents a significant barrier to research. The comments were part of a report on a spending bill that provides funding for several key agencies for fiscal year 2024. Psychedelic research may be a relatively new field, but it has attracted considerable attention from lawmakers and the general public due to its potentially game-changing findings. Studies…

WednesdayAug 09, 2023 1:52 pm

Animal Study Shows Psilocybin Fix Cognitive Deficits Resulting from Stress-Related Depression

A recent study published in the “Psychedelic Medicine” journal has reported that psilocybin possesses effects akin to antidepressants and may alleviate cognitive deficits resulting from chronic stress in animal models. Psilocybin is a hallucinogenic compound produced in magic mushrooms. Although it has been used recreationally for decades because of its hallucinatory effects, a growing body of research now shows that psilocybin may also have a myriad of mental health benefits. This research has found that psilocybin as well as other psychedelic compounds such as LSD and ayahuasca can treat various mental-health conditions, offering relatively long-term relief at low doses and…

TuesdayAug 08, 2023 12:10 pm

Study Compares Human Brains During Meditation, Hypnosis, Under Psychedelics

Researchers from the University of Zurich Psychiatric Hospital are comparing what happens to the human brain during meditation and hypnosis, as well as while under the effects of psychedelics. Brain changes while under the influence of drugs or during states such as hypnosis and meditation have been an object of interest for researchers for quite a while now. Now that psychedelics have emerged as potential mental health treatments with much higher success rates and fewer side effects, researchers are even more interested in how drugs like psychedelics cause changes in the brain. University of Zurich researchers were particularly interested in…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000